Exhibit 5.1

February 3, 2012

Medical Properties Trust, Inc.

MPT Operating Partnership, L.P.

MPT Finance Corporation

1000 Urban Center Drive, Suite 501

Birmingham, AL 35242

Ladies and Gentlemen:

We have acted as counsel to you in connection with your filing of a Registration Statement on Form S-3 (File No. 333-179320) (as amended or supplemented, the “Registration Statement”) filed on February 3, 2012 with the Securities and Exchange Commission (the “Commission”) pursuant to the Securities Act of 1933, as amended (the “Securities Act”), relating to the registration of (i) the Senior Notes due 2022 (the “Notes”) of MPT Operating Partnership, L.P., a Delaware limited partnership, and MPT Finance Corporation, a Delaware corporation (the “Issuers”) and (ii) the guarantees of the Notes (the “Guarantees”) by Medical Properties Trust, Inc., a Maryland corporation (the “Parent Guarantor”) and certain subsidiaries of the Parent Guarantor named in Schedule 1 (the “Subsidiary Guarantors,” and together with the Parent Guarantor, the “Guarantors”). The Registration Statement became effective upon filing with the Commission. Reference is made to our opinion letter dated February 3, 2012 and included as Exhibit 5.1 to the Registration Statement. We are delivering this supplemental opinion letter in connection with the final prospectus (the “Final Prospectus”) dated February 3, 2012 by the Issuers and the Parent Guarantor with the Commission pursuant to Rule 424 under the Securities Act. The Final Prospectus relates to the offering by the Issuers of up to $200,000,000 in aggregate principal amount of the Notes and the Guarantees covered by the Registration Statement. We understand that the Notes and the Guarantees are to be offered and sold in the manner described in the Final Prospectus.

We refer to the Indenture, to be dated as of February 17, 2012, that is to be entered into by the Issuers, the Guarantors and Wilmington Trust Company, as trustee (the “Trustee”), establishing the terms of the Notes and the Guarantees under such Indenture, in a form consistent with that authorized by the Issuers, as the “Indenture.”

We have reviewed such documents and made such examination of law as we have deemed appropriate to give the opinions set forth below. We have relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinions set forth below, on certificates of officers of the Parent Guarantor.

The opinions set forth below are limited to the Maryland General Corporation Law (which includes reported judicial decisions interpreting the Maryland General Corporation Law), the Delaware General Corporation Law (which includes reported judicial decisions interpreting

Medical Properties Trust, Inc.

MPT Operating Partnership, L.P.

MPT Finance Corporation

February 3, 2012

Page 2

the Delaware General Corporation Law), the Delaware Limited Liability Company Act, the Delaware Revised Uniform Limited Partnership Act and the law of New York. Without limiting the generality of the foregoing, we express no opinion with respect to (i) state securities or “blue sky” laws or (ii) state or federal antitrust laws.

Based on the foregoing, we are of the opinion that:

The opinions above are subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other similar laws of general application affecting the rights and remedies of creditors and to general principles of equity.

This opinion letter and the opinions it contains shall be interpreted in accordance with the Legal Opinion Principles issued by the Committee on Legal Opinions of the American Bar Association’s Business Law Section as published in 53 Business Lawyer 831 (May 1998).

We hereby consent to the inclusion of this opinion as Exhibit 5.1 to Medical Properties Trust, Inc.’s Current Report on Form 8-K to be filed on February 9, 2012, which will be incorporated by reference into the Registration Statement, and to the references to our firm therein and under the caption “Legal matters” in the Final Prospectus. In giving our consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.

SCHEDULE 1